Literature DB >> 16950068

Acetabular revision using a trabecular metal acetabular component for severe acetabular bone loss associated with a pelvic discontinuity.

Scott M Sporer1, Wayne G Paprosky.   

Abstract

Pelvic discontinuity can be encountered during acetabular revision in patients with severe bone loss. All patients who had an acetabular reconstruction for a type IIIB acetabular defect according to the classification of Paprosky et al [Paprosky WG, Perona PG, Lawrence JM. 1994. Acetabular defect classification and surgical reconstruction in revision arthroplasty. A 6-year follow-up evaluation. J Arthroplasty 9:33.] with an associated pelvic discontinuity between 2001 and 2003 were reviewed. A trabecular metal acetabular component with or that without an acetabular augment was used to obtain fixation proximal and distal to the discontinuity. Thirteen patients (13 hips) were treated for a type IIIB acetabular defect. At an average of 2.6 years of follow-up, 1 patient demonstrated possible radiographic loosening. The other 12 patients maintained radiographically stable hips. None of the patients required repeat surgical intervention. Clinically, the patients' modified Postel-Merle d'Aubigne score improved from 6.1 preoperatively to 10.3 postoperatively. The treatment of pelvic discontinuity during acetabular revision using a trabecular metal acetabular component with or that without an associated trabecular metal augment appears to provide reliable and reproducible short-term results.

Entities:  

Mesh:

Year:  2006        PMID: 16950068     DOI: 10.1016/j.arth.2006.05.015

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  45 in total

1.  Pelvic discontinuity treated with custom triflange component: a reliable option.

Authors:  Michael J Taunton; Thomas K Fehring; Paul Edwards; Thomas Bernasek; Ginger E Holt; Michael J Christie
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

2.  High failure rate with the GAP II ring and impacted allograft bone in severe acetabular defects.

Authors:  Martin A Buttaro; Diego Muñoz de la Rosa; Fernando Comba; Francisco Piccaluga
Journal:  Clin Orthop Relat Res       Date:  2012-11       Impact factor: 4.176

3.  Uncemented Porous Tantalum Acetabular Components: Early Follow-Up and Failures in 599 Revision Total Hip Arthroplasties.

Authors:  William J Long; Nicolas O Noiseux; Tad M Mabry; Arlen D Hanssen; David G Lewallen
Journal:  Iowa Orthop J       Date:  2015

4.  [Revision implants of the future: trends and new developments].

Authors:  S Winkler; F-X Köck; C Baier; H-R Springorum; A Beifuss; P Lechler; J Grifka; J Schaumburger
Journal:  Orthopade       Date:  2012-01       Impact factor: 1.087

5.  Acetabular revisions using a cementless oblong cup: five to ten year results.

Authors:  R Civinini; A Capone; C Carulli; M Villano; M I Gusso
Journal:  Int Orthop       Date:  2007-01-13       Impact factor: 3.075

6.  Acetabular cage survival and analysis of factors related to failure.

Authors:  Jonathan N Sembrano; Edward Y Cheng
Journal:  Clin Orthop Relat Res       Date:  2008-02-26       Impact factor: 4.176

Review 7.  Properties of open-cell porous metals and alloys for orthopaedic applications.

Authors:  Gladius Lewis
Journal:  J Mater Sci Mater Med       Date:  2013-07-13       Impact factor: 3.896

Review 8.  Classifications in brief: Paprosky classification of acetabular bone loss.

Authors:  Jessica J M Telleria; Albert O Gee
Journal:  Clin Orthop Relat Res       Date:  2013-08-31       Impact factor: 4.176

Review 9.  Systematic review on outcomes of acetabular revisions with highly-porous metals.

Authors:  Samik Banerjee; Kimona Issa; Bhaveen H Kapadia; Robert Pivec; Harpal S Khanuja; Michael A Mont
Journal:  Int Orthop       Date:  2013-11-01       Impact factor: 3.075

10.  Tantalum components in difficult acetabular revisions.

Authors:  Paul F Lachiewicz; Elizabeth S Soileau
Journal:  Clin Orthop Relat Res       Date:  2009-07-07       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.